Code Snippets
curl "https://financialdata.net/api/v1/stock-quotes?identifiers=GILD&key=API_KEY"import requests
url = 'https://financialdata.net/api/v1/stock-quotes?identifiers=GILD&key=API_KEY'
response = requests.get(url)
print(response.json())
const url = 'https://financialdata.net/api/v1/stock-quotes?identifiers=GILD&key=API_KEY';
const response = await fetch(url);
const data = await response.json();
console.log(data);
Sample Response
[
{
"trading_symbol": "GILD",
"registrant_name": "GILEAD SCIENCES, INC.",
"time": "2026-10-15 14:04:22",
"price": 158.59,
"change": 5.03,
"percentage_change": 3.27
},
...
]Query Parameters
| Name | Type | Description |
|---|---|---|
| identifiers | string | The trading symbols for the securities. (e.g., MSFT,AAPL) |
| format | string | (Optional) The format of the returned data, either JSON or CSV. Defaults to JSON. (e.g., json, csv) |
Endpoint Overview
Get real-time stock quotes, including the last price, change, and percentage change. The data covers several thousand US and international companies. The timezone used for time values is EST (Eastern Standard Time). There is a limit of 300 records per API call.
Company Profile
GILEAD SCIENCES, INC.
NASDAQ: GILD- Market Cap:$103.20B
- ISIN:US3755581036
- Fiscal Year End:12/31
- CEO:Daniel O'Day
- Employees:17000
Gilead Sciences, Inc. (/ˈɡɪliəd/) is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. It also develops medicines in therapeutic areas such as oncology and inflammation and cell therapy.
GILD Datasets
GILD Stock PricesGILD Minute PricesGILD Company InformationGILD Key MetricsGILD Market CapGILD Employee CountGILD Executive CompensationGILD Income StatementsGILD Balance Sheet StatementsGILD Cash Flow StatementsGILD Insider TransactionsGILD Senate TradingGILD Institutional HoldingsGILD Analyst ConsensusGILD Earnings ReleasesGILD Stock SplitsGILD DividendsGILD Short Interest